Myriad Genetics Inc (MYGN)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 252,200 | 236,200 | 202,000 | 197,600 | 178,200 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $252,200K ÷ $—K
= —
Based on the provided data, the payables turnover ratio for Myriad Genetics Inc is not available for the years 2020, 2021, 2022, 2023, and 2024. This indicates that specific information about the company's payables turnover, which measures how efficiently a company is managing its accounts payable, is not disclosed or readily accessible in the financial statements for these years. As a result, a detailed analysis of the company's payables turnover performance over this period cannot be conducted.
Peer comparison
Dec 31, 2024
Company name
Symbol
Payables turnover
Myriad Genetics Inc
MYGN
—
IDEXX Laboratories Inc
IDXX
—
Lantheus Holdings Inc
LNTH
—
Neogen Corporation
NEOG
—
Quidel Corporation
QDEL
—